More healthcare startups are choosing to go public through mergers with special-purpose acquisition companies— publicly-traded shell companies created with the purpose of taking a private company public. But as the number of SPACs searching for targets increases, will the SPAC bubble burst?
The three-year-old digital health startup began trading on the New York Stock Exchange on Thursday. It merged with a subsidiary of Oaktree Capital Management in a deal that valued the company at $1.6 billion.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Hims, a men’s wellness startup that offers hair loss treatments, mail order supplements and other wellness tools, is expanding into the mental health space. The company is offering virtual psychiatry consultations and plans to offer one-on-one therapy in the future.
Oschner will partner with mail-order health company Hims & Hers to screen patients for blood pressure or diabetes.
Behind companies like Hims, Nurx and Lemonaid sits Truepill's technology, which handles the logistics, shipping and pharmacy fulfillment necessary to run the direct-to-consumer businesses.
Healthcare investing reached record new highs in 2018, hitting more than $30 billion across all sectors, according to numbers from Pitchbook.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.